Watch for Dovato, a New Two-Med Combo for HIV
July 2019
Dovato (doh-VAH-toh) will be a new complete HIV regimen with TWO meds in one pill...for treatment-naive patients.
It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.
Dovato will try to compete with Biktarvy and Triumeq. These THREE-med one-pill combos have an integrase inhibitor...plus TWO nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote